Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
Mammographic density, breast cancer risk and risk prediction
2007
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
2014 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
The Real Contribution of the Major Risk Factors to the Coronary Epidemics
2001
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
1994
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations
2000
The metabolic syndrome
2010 Standout
Selected major risk factors and global and regional burden of disease
2002 Standout
Correcting for multivariate measurement error by regression calibration in meta‐analyses of epidemiological studies
2009
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Cell-free DNA Analysis for Noninvasive Examination of Trisomy
2015 Standout
Parkinson's disease
2009 Standout
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
2005
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Premature cardiovascular disease in chronic renal failure
2000
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: A 16-year follow-up of the Primary Prevention Study in Gateborg, Sweden
1997
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Cardiovascular Disease Mortality and Cancer Incidence in Vegetarians: A Meta-Analysis and Systematic Review
2012
Risk factor thresholds: their existence under scrutiny
2002
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
2003
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Periodontal diseases
2005 Standout
A strategy to reduce cardiovascular disease by more than 80%
2003 Standout
Global diets link environmental sustainability and human health
2014 StandoutNature
Effects of Sirolimus on Lipids in Renal Allograft Recipients: An Analysis Using the Framingham Risk Model
2002
Cigarette Smoking and the Periodontal Patient
2004
Global burden of blood-pressure-related disease, 2001
2008 Standout
Atherosclerosis
2000 StandoutNature
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
2009 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice
1999
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
2006 Standout
Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts
2008
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
1995 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Randomized Trial of Folic Acid Supplementation and Serum Homocysteine Levels
2001
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Dietary habits and mortality in 11 000 vegetarians and health conscious people: results of a 17 year follow up
1996
NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome Aneuploidy
2012
Cigarette exposure induces changes in maternal vascular function in a pregnant mouse model
2010
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Impact of Tobacco Use on Periodontal Status
2001
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Brain monoamine oxidase A inhibition in cigarette smokers
1996
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
2001 Standout
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations
1999
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
2007 Standout
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations
1999
Dietary determinants of ischaemic heart disease in health conscious individuals
1997
Balancing Life-Style and Genomics Research for Disease Prevention
2002 Science
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009 Standout
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
General Cardiovascular Risk Profile for Use in Primary Care
2008 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Primary Prevention of Coronary Heart Disease
1999
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Works of A Hackshaw being referenced
Response to: Wald, N.J., Hackshaw, A.K. (1997). Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome, Prenat. Diagn., 17, 821-829. Authors' reply
1998
Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study
1994
When can a risk factor be used as a worthwhile screening test?
1999
SURUSS in perspective
2004
Cigarette smoking: an epidemiological overview
1996
DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.
1994